timolol has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergler-Czop, B; Bilewicz-Stebel, M; Miziołek, B; Stańkowska, A | 1 |
1 review(s) available for timolol and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Female; Follow-Up Studies; Glaucoma; Humans; Lupus Erythematosus, Cutaneous; Risk Assessment; Severity of Illness Index; Timolol; Withholding Treatment | 2018 |